| Predictable modulation of cancer treatment outcomes by the gut microbiota Y Heshiki, R Vazquez-Uribe, J Li, Y Ni, S Quainoo, L Imamovic, J Li, ... Microbiome 8, 1-14, 2020 | 116 | 2020 |
| Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria B Seelbinder, J Chen, S Brunke, R Vazquez-Uribe, R Santhaman, ... Microbiome 8, 1-20, 2020 | 90* | 2020 |
| Altering microbial populations and modifying microbiota J Clube, M Sommer, C Grøndahl, E VAN DER HELM, R Vazquez-uribe US Patent 9,701,964, 2017 | 76* | 2017 |
| Discovery and characterization of Cas9 inhibitors disseminated across seven bacterial phyla RV Uribe, E van der Helm, MA Misiakou, SW Lee, S Kol, MOA Sommer Cell host & microbe 25 (2), 233-241. e5, 2019 | 73 | 2019 |
| Bacterial resistance to CRISPR-Cas antimicrobials RV Uribe, C Rathmer, LJ Jahn, MMH Ellabaan, SS Li, MOA Sommer Scientific Reports 11 (1), 17267, 2021 | 33 | 2021 |
| Metabolic modeling predicts specific gut bacteria as key determinants for Candida albicans colonization levels MH Mirhakkak, S Schäuble, TE Klassert, S Brunke, P Brandt, D Loos, ... The ISME journal 15 (5), 1257-1270, 2021 | 29 | 2021 |
| Single-vector type i vectors V Martinez, R Vazquez-uribe, A Takos, E VAN DER HELM, J Clube US Patent App. 16/201,736, 2020 | 21 | 2020 |
| The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity KJ Forsberg, DT Schmidtke, R Werther, RV Uribe, D Hausman, ... PLoS biology 19 (10), e3001428, 2021 | 19* | 2021 |
| Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract KA Hedin, VE Rees, H Zhang, V Kruse, R Vazquez-Uribe, MOA Sommer Scientific Reports 12 (1), 8862, 2022 | 14 | 2022 |
| Escherichia coli Promoters with Consistent Expression throughout the Murine Gut J Armetta, M Schantz-Klausen, D Shepelin, R Vazquez-Uribe, MI Bahl, ... ACS Synthetic Biology 10 (12), 3359-3368, 2021 | 11 | 2021 |
| Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions B Seelbinder, Z Lohinai, R Vazquez-Uribe, S Brunke, X Chen, ... Nature Communications 14 (1), 2673, 2023 | 8 | 2023 |
| Biocontainment strategies for in vivo applications of Saccharomyces boulardii KA Hedin, V Kruse, R Vazquez-Uribe, MOA Sommer Frontiers in Bioengineering and Biotechnology 11, 213, 2023 | 7 | 2023 |
| Characterization of Eight Bacterial Biosensors for Microbial Diagnostic and Therapeutic Applications TH Vaaben, R Vazquez-Uribe, MOA Sommer ACS Synthetic Biology 11 (12), 4184-4192, 2022 | 5 | 2022 |
| Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening SW Lee, KT Tran, R Vazquez-Uribe, CH Gotfredsen, MH Clausen, ... Journal of Medicinal Chemistry 65 (4), 3266-3305, 2022 | 5 | 2022 |
| Cold exposure and oral delivery of GLP-1R agonists by an engineered probiotic yeast strain have antiobesity effects in mice KA Hedin, H Zhang, V Kruse, VE Rees, F Backhed, TU Greiner, ... ACS Synthetic Biology 12 (11), 3433-3442, 2023 | 3* | 2023 |
| Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy S Tumas, TS Meldgaard, TH Vaaben, S Suarez Hernandez, ... Scientific Reports 13 (1), 12506, 2023 | 3 | 2023 |
| Screening for effective cell-penetrating peptides with minimal impact on epithelial cells and gut commensals in vitro HP Gelli, R Vazquez-Uribe, MOA Sommer Frontiers in Pharmacology 13, 1049324, 2022 | 3 | 2022 |
| Challenging the Hypothesis of de novo Biosynthesis of Bile Acids by Marine Bacteria FG Tueros, MMH Ellabaan, M Henricsson, R Vazquez-Uribe, F Backhed, ... Microbiology and Biotechnology Letters 50 (1), 102-109, 2022 | 2 | 2022 |
| Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model V Iannone, AF Babu, J Lok, C Gómez-Gallego, G D'Auria, ... Molecular Metabolism 78, 101823, 2023 | 1 | 2023 |
| AI is a viable alternative to high throughput screening: a 318-target study Scientific Reports 14 (1), 7526, 2024 | | 2024 |
Morten O A SommerProfessor, Technical University of DenmarkVerified email at bio.dtu.dk
